Last reviewed · How we verify
Abhayrab rabies vaccine — Competitive Intelligence Brief
phase 2
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Abhayrab rabies vaccine (Abhayrab rabies vaccine) — PATH. Abhayrab rabies vaccine works by stimulating the body's immune system to produce antibodies against rabies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Abhayrab rabies vaccine TARGET | Abhayrab rabies vaccine | PATH | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Abhayrab rabies vaccine CI watch — RSS
- Abhayrab rabies vaccine CI watch — Atom
- Abhayrab rabies vaccine CI watch — JSON
- Abhayrab rabies vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Abhayrab rabies vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/abhayrab-rabies-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab